{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:40:05Z","timestamp":1747237205884,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007543","name":"ANSM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tracli.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T17:09:17Z","timestamp":1739207357000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac serious adverse reactions in donors in France 2010\u201321"],"prefix":"10.1016","volume":"32","author":[{"given":"Karim","family":"Boudjedir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Michel","family":"Mertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Somme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marine","family":"Lenzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Foll\u00e9a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2025.02.002_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/vox.12323","article-title":"Development of standard definitions for surveillance of complications related to blood donation","volume":"110","author":"Goldman","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.02.002_b0010","unstructured":"European Commission. Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components. https:\/\/ec.europa.eu\/health\/sites\/default\/files\/blood_tissues_organs\/docs\/2019_sare_blood_summary_en.pdf (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/vox.13014","article-title":"Putting the spotlight on donation-related risks and donor safety \u2013 are we succeeding in protecting donors?","volume":"116","author":"Mikkelsen","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.02.002_b0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/vox.13028","article-title":"How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project","volume":"116","author":"Mikkelsen","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.02.002_b0025","article-title":"ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes","author":"Byrne","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.tracli.2025.02.002_b0030","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. D\u00e9cision du 1er juin 2010 fixant la forme, le contenu et les modalit\u00e9s de transmission de la fiche de d\u00e9claration d'effet ind\u00e9sirable grave survenu chez un donneur de sang. JORF n\u00b00180 du 6 ao\u00fbt 2010. http:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000022673703 (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0035","unstructured":"Le Manach Y, Gibert H. Isch\u00e9mie coronaire per et postop\u00e9ratoire : diagnostics et \u00e9pid\u00e9miologie en 2012. In: Communications scientifiques MAPAR 2012 : Mises Au Point en Anesth\u00e9sie-R\u00e9animation. MAPAR \u00e9ditions 2012. p. 99\u2013103."},{"key":"10.1016\/j.tracli.2025.02.002_b0040","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/cvr\/cvaa331","article-title":"Cardiac troponin and defining myocardial infarction","volume":"117","author":"Kaier","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.tracli.2025.02.002_b0045","unstructured":"Caisse Primaire d\u2019Assurance Maladie. Le risque cardiovasculaire et ses facteurs; 2022. https:\/\/www.ameli.fr\/assure\/sante\/themes\/risque-cardiovasculaire\/definition-facteurs-favorisants (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0050","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tracli.2025.02.002_b0055","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Table d\u2019indice de masse corporelle. 2009. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2009-09\/table_imc_230909.pdf (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0060","unstructured":"AFSSaPS. Rapport annuel H\u00e9movigilance 2010. Rapport H\u00e9movigilance 2010 (hemovigilance-cncrh.fr). (accessed15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0065","unstructured":"ANSM. 19\u00e8me Rapport national d\u2019h\u00e9movigilance. Rapport 2021 - liste des tables (sante.fr) (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1423-0410.1999.7710024.x","article-title":"Adverse events in platelet apheresis donors: a multivariate analysis in a hospital-based program","volume":"77","author":"Despotis","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.02.002_b0075","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.ijcard.2010.02.069","article-title":"Acute myocardial infarction secondary to platelet apheresis in a 57-year healthy donor","volume":"150","author":"Rosencher","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tracli.2025.02.002_b0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tracli.2013.02.019","article-title":"L'h\u00e9movigilance des donneurs de sang en France [The blood donors' haemovigilance in France]","volume":"20","author":"Ounnoughene","year":"2013","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2025.02.002_b0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tracli.2015.06.052","article-title":"Effets ind\u00e9sirables cardio-vasculaires chez les donneurs de sang total et en aph\u00e9r\u00e8se : une \u00e9tude cas-t\u00e9moin","volume":"22","author":"Narbey","year":"2015","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2025.02.002_b0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/trf.13475","article-title":"Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data","volume":"56","author":"Daurat","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.02.002_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jca.2920090104","article-title":"Prolonged circulation of activated platelets following plasmapheresis","volume":"9","author":"Wun","year":"1994","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2025.02.002_b0100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1537-2995.1997.37897424403.x","article-title":"Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis","volume":"37","author":"Gutensohn","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.02.002_b0105","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1537-2995.2006.00934.x","article-title":"Blood volume regulation in donors undergoing intermittent-flow plasmapheresis involving a high extracorporeal blood volume","volume":"46","author":"Karger","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.02.002_b0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.transci.2006.10.005","article-title":"Double dose plateletpheresis by continuous and intermittent flow devices increases platelet-neutrophil complex formation in healthy donors without noticeable neutrophil activation","volume":"36","author":"Bilgin","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2025.02.002_b0115","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Arr\u00eat\u00e9 du 17 d\u00e9cembre 2019 fixant les crit\u00e8res de s\u00e9lection des donneurs de sang. Arr\u00eat\u00e9 du 17 d\u00e9cembre 2019 fixant les crit\u00e8res de s\u00e9lection des donneurs de sang - L\u00e9gifrance (legifrance.gouv.fr) (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/voxs.12367","article-title":"Our older population: donors as well as recipients?","volume":"12","author":"Goldman","year":"2017","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2025.02.002_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/voxs.12634","article-title":"Still willing and able to contribute: donor perspectives on donating blood in later life","volume":"16","author":"Thorpe","year":"2021","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2025.02.002_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.transci.2013.06.018","article-title":"The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention","volume":"49","author":"Kessler","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2025.02.002_b0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tmrv.2011.05.002","article-title":"Proceedings of a consensus conference: risk-Based Decision Making for Blood Safety","volume":"25","author":"Leach Bennett","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2025.02.002_b0140","unstructured":"Commission of the European Communities. Commission Directive 2005\/61\/EC of 30 September 2005 implementing Directive 2002\/98\/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events. EUR-Lex - 32005L0061 - EN - EUR-Lex (europa.eu) (accessed 15\/10\/2024)."},{"key":"10.1016\/j.tracli.2025.02.002_b0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.aje.a009669","article-title":"Donation of blood is associated with reduced risk of myocardial infarction the Kuopio Ischaemic Heart disease risk factor study","volume":"148","author":"Salonen","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tracli.2025.02.002_b0150","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1537-2995.2002.00186.x","article-title":"A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events","volume":"42","author":"Meyers","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.02.002_b0155","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/trf.13205","article-title":"Blood donation and blood donor mortality after adjustment for a healthy donor effect","volume":"55","author":"Ullum","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.02.002_b0160","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/heartjnl-2018-314138","article-title":"Cardiovascular risk in 159 934 frequent blood donors while addressing the healthy donor effect","volume":"105","author":"Peffer","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.tracli.2025.02.002_b0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2019.12.011","article-title":"Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors","volume":"186","author":"Hultcrantz","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.tracli.2025.02.002_b0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tmrv.2022.04.004","article-title":"Cardiovascular benefits for blood donors? A systematic review","volume":"36","author":"Quee","year":"2022","journal-title":"Transfus Med Rev"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678202500028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678202500028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:12:51Z","timestamp":1747235571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S124678202500028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S124678202500028X"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2025.02.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac serious adverse reactions in donors in France 2010\u201321","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\ufffdt\ufffd francophone de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}